Long-term NMDAR antagonism correlates reduced astrocytic glutamate uptake with anxiety-like phenotype

Frontiers in Cellular Neuroscience

Volumn 9, Issue JUNE, 2015, Pages

  Zimmer, Eduardo R ^a   Torrez, Vitor R ^a   Kalinine, Eduardo ^a,b   Augustin, Marina C ^a   Zenki, Kamila C ^a   Almeida, Roberto F ^a   Hansel, Gisele ^a   Muller, Alexandre P ^a,c   Souza, Diogo O ^a   Machado Vieira, Rodrigo ^d,e   Portela, Luis V ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^c UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Anxiety; Astrocytes; Behavior; Glutamate; Memantine

Indexed keywords

GLUTAMATE TRANSPORTER; GLUTAMIC ACID; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DRUG ANTAGONISM; ELEVATED PLUS MAZE TEST; FRONTOPARIETAL CORTEX; HIPPOCAMPUS; HISTOPATHOLOGY; MOUSE; NONHUMAN; OPEN FIELD TEST; PHENOTYPE; PROTEIN EXPRESSION; TIME; WESTERN BLOTTING;

EID: 84934890468     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00219     Document Type: Article

References (39)

1. Abramoff, M. D., Magalhaes, P. J., and Ram, S. J. (2004). Processing with ImageJ. Biophotonics Intern. 11, 36-42.
2. Anderson, C. M., and Swanson, R. A. (2000). Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 32, 1-14. doi: 10.1002/1098-1136(200010)32:1<1::AID-GLIA10>3.0.CO;2-W
3. Bechtholt-Gompf, A. J., Walther, H. V., Adams, M. A., Carlezon, W. A. Jr., Ongur, D., and Cohen, B. M. (2010). Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory. Neuropsychopharmacology 35, 2049-2059. doi: 10.1038/npp.2010.74
4. Clement, Y., and Chapouthier, G. (1998). Biological bases of anxiety. Neurosci. Biobehav. Rev. 22, 623-633. doi: 10.1016/S0149-7634(97)00058-4
5. Cortese, B. M., and Phan, K. L. (2005). The role of glutamate in anxiety and related disorders. CNS Spectr. 10, 820-830.
6. Crawley, J., and Goodwin, F. K. (1980). Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol. Biochem. Behav. 13, 167-170. doi: 10.1016/0091-3057(80)90067-2
7. Danbolt, N. C. (2001). Glutamate uptake. Prog. Neurobiol. 65, 1-105. doi: 10.1016/S0301-0082(00)00067-8
8. Danbolt, N. C., Storm-Mathisen, J., and Kanner, B. I. (1992). An [Na+ + K+]coupled L-glutamate transporter purified from rat brain is located in glial cell processes. Neuroscience 51, 295-310. doi: 10.1016/0306-4522(92)90316-T
9. Gross, C., and Hen, R. (2004). The developmental origins of anxiety. Nat. Rev. Neurosci. 5, 545-552. doi: 10.1038/nrn1429
10. Hanson, J. E., Meilandt, W. J., Gogineni, A., Reynen, P., Herrington, J., Weimer, R. M., et al. (2014). Chronic GluN2B antagonism disrupts behavior in wild-type mice without protecting against synapse loss or memory impairment in Alzheimer's disease mouse models. J. Neurosci. 34, 8277-8288. doi: 10.1523/JNEUROSCI.5106-13.2014
11. John, C. S., Sypek, E. I., Carlezon, W. A., Cohen, B. M., Ongur, D., and Bechtholt, A. J. (2015). Blockade of the GLT-1 transporter in the central nucleus of the amygdala induces both anxiety and depressive-like symptoms.Neuropsychopharmacology 40, 1700-1708. doi: 10.1038/npp.2015.16
12. Karus, C., Mondragao, M. A., Ziemens, D., and Rose, C. R. (2015). Astrocytes restrict discharge duration and neuronal sodium loads during recurrent network activity. Glia 63, 936-957. doi: 10.1002/glia.22793
13. Leasure, J. L., and Decker, L. (2009). Social isolation prevents exercise-induced proliferation of hippocampal progenitor cells in female rats. Hippocampus 19, 907-912. doi: 10.1002/hipo.20563
14. Lee, Y., Son, H., Kim, G., Kim, S., Lee, D. H., Roh, G. S., et al. (2013). Glutamine deficiency in the prefrontal cortex increases depressive-like behaviours in male mice. J. Psychiatry Neurosci. 38, 183-191. doi: 10.1503/jpn.120024
15. Lehre, K. P., and Danbolt, N. C. (1998). The number of glutamate transporter subtype molecules at glutamatergic synapses: chemical and stereological quantification in young adult rat brain. J. Neurosci. 18, 8751-8757.
16. + entry and protein kinase C in rat cerebral cortex nerve terminals: an NMDA receptor-independent mechanism.Neurochem. Int. 57, 168-176. doi: 10.1016/j.neuint.2010.05.010
17. Machado-Vieira, R., Ibrahim, L., Henter, I. D., and Zarate, C. A. Jr. (2012). Novel glutamatergic agents for major depressive disorder and bipolar disorder. Pharmacol. Biochem. Behav. 100, 678-687. doi: 10.1016/j.pbb.2011.09.010
18. Machado-Vieira, R., Manji, H. K., and Zarate, C. A. (2009). The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders. Neuroscientist 15, 525-539. doi: 10.1177/1073858409336093
19. Minkeviciene, R., Banerjee, P., and Tanila, H. (2008). Cognition-enhancing and anxiolytic effects of memantine.Neuropharmacology 54, 1079-1085. doi: 10.1016/j.neuropharm.2008.02.014
20. Muller, A. P., Zimmer, E. R., Kalinine, E., Haas, C. B., Oses, J. P., Martimbianco De Assis, A., et al. (2012). Physical exercise exacerbates memory deficits induced by intracerebroventricular STZ but improves insulin regulation of H2O2 production in mice synaptosomes. J. Alzheimers Dis. 30, 889-898. doi: 10.3233/JAD-2012-112066
21. Nemeroff, C. B. (2003). The role of GABA in the pathophysiology and treatment of anxiety disorders. Psychopharmacol. Bull. 37, 133-146.
22. Nutt, D. J., and Malizia, A. L. (2001). New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder. Br. J. Psychiatry 179, 390-396. doi: 10.1192/bjp.179.5.390
23. Pellow, S. (1986). Anxiolytic and anxiogenic drug effects in a novel test of anxiety: are exploratory models of anxiety in rodents valid? Methods Find Exp. Clin. Pharmacol. 8, 557-565.
24. Peterson, G. L. (1977). A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 83, 346-356. doi: 10.1016/0003-2697(77)90043-4
25. Pilc, A., Wierońska, J. M., and Skolnick, P. (2013). Glutamate-based antidepressants: preclinical psychopharmacology. Biol. Psychiatry 73, 1125-1132. doi: 10.1016/j.biopsych.2013.01.021
26. Reus, G. Z., Stringari, R. B., Kirsch, T. R., Fries, G. R., Kapczinski, F., Roesler, R., et al. (2010). Neurochemical and behavioural effects of acute and chronic memantine administration in rats: further support for NMDA as a new pharmacological target for the treatment of depression? Brain Res. Bull. 81, 585-589. doi: 10.1016/j.brainresbull.2009.11.013
27. Riaza Bermudo-Soriano, C., Perez-Rodriguez, M. M., Vaquero-Lorenzo, C., and Baca-Garcia, E. (2012). New perspectives in glutamate and anxiety. Pharmacol. Biochem. Behav. 100, 752-774. doi: 10.1016/j.pbb.2011.04.010
28. Sani, G., Serra, G., Kotzalidis, G. D., Romano, S., Tamorri, S. M., Manfredi, G., et al. (2012). The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence. CNS Drugs26, 663-690. doi: 10.2165/11634390-000000000-00000
29. Schroeter, M. L., Abdul-Khaliq, H., Sacher, J., Steiner, J., Blasig, I. E., and Mueller, K. (2010). Mood disorders are glial disorders: evidence from in vivo studies. Cardiovasc. Psychiatry Neurol. 2010:780645. doi: 10.1155/2010/780645
30. Schwartz, T. L., Siddiqui, U. A., and Raza, S. (2012). Memantine as an augmentation therapy for anxiety disorders. Case Rep. Psychiatry 2012:749796. doi: 10.1155/2012/749796
31. Silvestre, J. S., Nadal, R., Pallares, M., and Ferre, N. (1997). Acute effects of ketamine in the holeboard, the elevated-plus maze, and the social interaction test in Wistar rats. Depress. Anxiety 5, 29-33. doi: 10.1002/(SICI)1520-6394(1997)5:1<29::AID-DA5>3.0.CO;2-0
32. Solati, J. (2011). Dorsal hippocampal N-methyl-d-aspartate glutamatergic and delta-opioidergic systems modulate anxiety behaviors in rats in a noninteractive manner. Kaohsiung J. Med. Sci. 27, 485-493. doi: 10.1016/j.kjms.2011.06.011
33. Szabo, S. T., Machado-Vieira, R., Yuan, P., Wang, Y., Wei, Y., Falke, C., et al. (2009). Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania. Neuropharmacology 56, 47-55. doi: 10.1016/j.neuropharm.2008.08.015
34. Tariot, P. N., Farlow, M. R., Grossberg, G. T., Graham, S. M., Mcdonald, S., and Gergel, I. (2004). Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA 291, 317-324. doi: 10.1001/jama.291.3.317
35. Thomazi, A. P., Godinho, G. F., Rodrigues, J. M., Schwalm, F. D., Frizzo, M. E., Moriguchi, E., et al. (2004). Ontogenetic profile of glutamate uptake in brain structures slices from rats: sensitivity to guanosine. Mech. Ageing Dev. 125, 475-481. doi: 10.1016/j.mad.2004.04.005
36. Wade, J., Mcdaid, L., Harkin, J., Crunelli, V., and Kelso, S. (2013). Biophysically based computational models of astrocyte ∼ neuron coupling and their functional significance. Front. Comput. Neurosci. 7:44. doi: 10.3389/fncom.2013.00044
37. Zarate, C. Jr., Machado-Vieira, R., Henter, I., Ibrahim, L., Diazgranados, N., and Salvadore, G. (2010). Glutamatergic modulators: the future of treating mood disorders? Harv. Rev. Psychiatry 18, 293-303. doi: 10.3109/10673229.2010.511059
38. Zhou, Y., and Danbolt, N. C. (2014). Glutamate as a neurotransmitter in the healthy brain. J. Neural. Transm. 121, 799-817. doi: 10.1007/s00702-014-1180-8
39. Zimmer, E. R., Kalinine, E., Haas, C. B., Torrez, V. R., Souza, D. O., Muller, A. P., et al. (2012). Pretreatment with memantine prevents Alzheimer-like alterations induced by intrahippocampal okadaic acid administration in rats. Curr. Alzheimer Res. 9, 1182-1190. doi: 10.2174/156720512804142877